Related Experiment Video
Updated: Jun 22, 2026

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
Published on: April 3, 2026
Preemptive analgesia reduces pain after radical axillary lymph node dissection
Heiko Neuss1, Gerold Koplin, Oliver Haase
1Department of General, Visceral, Thoracic, and Vascular Surgery, Medical Faculty of the Humboldt University, Berlin, Germany. heiko.neuss@charite.de
Preemptive Parecoxib significantly reduced pain and fatigue in melanoma patients after radical axillary lymph node dissection (RALND). This analgesic approach improved patient outcomes and decreased the need for postoperative pain medication.
Area of Science:
- Oncology
- Pain Management
- Clinical Trials
Background:
- Melanoma patients undergoing radical axillary lymph node dissection (RALND) often experience significant pain during mobilization.
- A prospective analysis revealed suboptimal pain scores post-RALND, necessitating investigation into improved pain management strategies.
Purpose of the Study:
- To evaluate the efficacy of preemptive Parecoxib administration in mitigating pain and improving outcomes for melanoma patients undergoing RALND.
- To assess the impact of perioperative Parecoxib on postoperative pain, fatigue, analgesic requirements, and length of hospital stay.
Main Methods:
- A randomized, double-blind clinical trial involving 32 stage III/IV melanoma patients undergoing RALND.
- Patients received either 40 mg intravenous Parecoxib or a saline placebo 2 hours prior to surgery.
- Pain was assessed using a visual analogue scale (VAS) on the first postoperative morning; secondary outcomes included complications, fatigue, and discharge day.
Main Results:
- Patients receiving preemptive Parecoxib demonstrated significantly reduced pain scores upon mobilization on postoperative day one (P = 0.04).
- The treatment group also reported significantly less fatigue (P = 0.05) and required a reduced amount of postoperative pain medication (P = 0.04).
Conclusions:
- Preemptive administration of Parecoxib is an effective strategy for enhancing patient outcomes following RALND in melanoma patients.
- Perioperative Parecoxib should be considered as a recommended analgesic intervention in the management of melanoma patients undergoing RALND.
Related Concept Videos
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Peripheral Artery Disease V: Postoperative Nursing Management
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Analgesia and Pain Management
Local Anesthetics: Clinical Application as Spinal Anesthesia
